Features | Partner Sites | Information | LinkXpress
Sign In
PURITAN MEDICAL
Bio-Rad Diabetes Division
FOCUS DIAGNOSTICS, INC.

IVD Market Expected to Grow Substantially in 2012-2014

By Labmedica International staff writers
Posted on 13 Dec 2011
The global in vitro diagnostics (IVD) market is expected to grow in 2012-2014 following a surge in Mergers and Acquisitions (M&A) deal values, an acceleration of companion diagnostics partnerships, and the emergence of new prospects for early detection testing, according to Diagnostics 2011, PwC's (New York, NY, USA) biennial review of the IVD sector.

Financial investors, life sciences research groups, clinical laboratories, and medical technology players are all entering the IVD market. Multibillion dollar IVD deals in first seven months of 2011 more than triple total M&A deal value from 2010 to more than US $15 billion.

Several companies are driving the development of a wave of new tests for early detection of major cancers. If the market adopts the concept of using noninvasive in vitro diagnostics for early detection, a major diagnostics or pharmaceutical company could move to acquire one or several of the promising new ventures in this field.

"The IVD sector has attracted exceptional levels of interest, especially reflected in the acceleration of companion diagnostics partnerships with pharmaceutical companies. This momentum will continue as long as innovation and growth prospects in key market segments, such as molecular and tissue diagnostics, remain strong, and rapid action is taken by stakeholders to create a favorable environment for sustaining such innovation, including pricing, regulatory pathways, clinical trial design, reimbursement, and drug-diagnostic value-sharing," said Loic Kubitza, director, pharmaceutical & life sciences advisory services, PwC Luxembourg, and author of the Diagnostics 2011 report.

PwC's Pharmaceutical, Medical Device and Life Sciences industry group is dedicated to delivering effective solutions to the strategic, operational and financial challenges facing pharmaceutical, biotechnology and medical device companies.

Related Links:

PwC





DIASYS DIAGNOSTIC SYSTEMS
KARL HECHT GMBH & CO KG
77 ELEKTRONIKA

Channels

Hematology

view channel
Image: The ADVIA 2120 Hematology System (Photo courtesy of Siemens).

Preoperative Blood Cell Ratios Predict Endometrial Cancer Survival

The variations in systemic inflammatory response biomarker levels have been associated with adverse clinical outcome in various malignancies and the host response to malignant tumors is characterized by... Read more

Immunology

view channel
Image: The Covaris S2 Ultrasonicator for shearing DNA (Photo courtesy of Covaris).

Genetic Mutation Impairs Immunity in Candidiasis and Mycobacteriosis

Human inborn errors of immunity mediated by the cytokines interleukin-17A/F (IL-17A/F) underlie mucocutaneous candidiasis, whereas inborn errors of interferon-γ (IFN-γ) immunity underlie mycobacterial disease.... Read more

Microbiology

view channel
Image: Transmission electron micrograph (TEM) of norovirus virions, or virus particles (Photo courtesy of Charles D. Humphrey/CDC).

Immunochromatography Tests Evaluated for Detection of Novel Norovirus

A novel GII.17 Norovirus has emerged as a major cause of epidemic and endemic acute gastroenteritis in several countries in Asia. From September 2014 to March 2015, 70% of all outbreaks in Guangdong... Read more

Lab Tech.

view channel
Image: Verigene System instrumentation consists of a Verigene Reader and one or multiple Verigene Processor SPs (Photo courtesy of Nanosphere).

Directed Molecular Diagnostic Tests Highlight Recent Microbiology Conference

The performance of a series of directed molecular diagnostic tests was confirmed by several studies presented at a recent microbiology conference. Nanosphere (Northbrook, IL, USA) manufactures tests... Read more
 
Copyright © 2000-2015 Globetech Media. All rights reserved.